From health to hair care, the experts broke down exactly how artificial intelligence is shaping Black futures and why we can’t afford to sit this one out.

In Hazle Twp. on the end of a road in Humboldt Industrial Park, Michaels Stores wants to make its distribution center part of ...

Over the last 7 days, the United States market has risen 2.1%, contributing to a notable 14% climb over the past year, with earnings expected to grow by 15% annually. In this favorable environment, ...

Neurocrine Biosciences' potential shines with robust assets, strong pipeline, and growth opportunities. Learn more about NBIX ...

Second, SoFi could grow its revenue even without expanding its membership base, by cross-selling additional products to its ...

Merck’s stock fell 1.77% to $80.93 while the market gained, despite rising 5.26% over the past month. The company’s upcoming ...

Merck & Co., Inc. (NYSE:MRK) ranks among the best set-it-and-forget-it stocks to buy. On June 27, TD Cowen maintained its ...

Merck (MRK) ended the recent trading session at $80.93, demonstrating a -1.77% change from the preceding day's closing price. This change lagged the S&P 500's daily gain of 0.83%. At the same time, ...

The stock's fall snapped a four-day winning streak.

Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% ...

Identifying stocks to buy and hold for decades rather than months or years can be difficult. The world and the economy are constantly changing, creating risks for long-term investors.

Merck’s MRK blockbuster PD-L1 inhibitor, Keytruda, approved for several types of cancer indications, is the company's biggest ...